CARLSBAD, Calif., Feb. 3, 2011 /PRNewswire/ — SkinMedica, Inc.,
the fastest-growing professional skin care company in the United
States, today announced that it is introducing a new, fast-acting
anti-redness product, Redness Relief CalmPlex™—the
biggest innovation in redness in over two decades. It is the
first and only non-prescription product clinically proven to reduce
This revolutionary formula contains, CalmPlex™, a
patented, nature-inspired ingredient that treats the underlying
causes of redness by inhibiting the release of a key natural
vasodilator as well as niacinamide which helps to strengthen the
skin by supporting the barrier function.
“Visible redness is a real and emotional burden for millions of
people,” commented SkinMedica Founder, Richard Fitzpatrick, MD.
“As dermatologists, we have been frustrated by the lack of
effective approaches to reducing the appearance of redness.
Backed by solid science and clinical results, Redness Relief
CalmPlex™ represents a truly novel advance in the skin
Ideal for sensitive skin types, this non-comedogenic formula
contains no added fragrance and offers relief and results to
improve overall skin appearance by neutralizing unwanted
In multiple clinical studies, Redness Relief CalmPlex™
demonstrated efficacy in relieving visible redness and improving
overall skin tone. SkinMedica Redness Relief CalmPlex™
demonstrated a 40% reduction in UV-induced redness in as early as 3
days. Redness Relief CalmPlex™ also provided significant
reductions in chronic redness after 1 week with continued
improvement through week twelve.